Literature DB >> 10844017

Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

G L Snyder1, P B Allen, A A Fienberg, C G Valle, R L Huganir, A C Nairn, P Greengard.   

Abstract

The activation of cAMP-dependent protein kinase regulates the physiological activity of AMPA-type glutamate receptors. In this study, phosphorylation of the AMPA receptor subunit GluR1 at Ser(845) was increased in neostriatal slices by activation of D1-type dopamine receptors and by inhibitors of protein phosphatase 1/protein phosphatase 2A. In contrast, Ser(831), a residue which, when phosphorylated by protein kinase C or calcium/calmodulin-dependent kinase II, increases AMPA receptor channel conductance, was unaffected by either D1 or D2 receptor agonists in neostriatal slices. The phosphorylation of Ser(845), but not Ser(831), was strongly increased in neostriatum in vivo in response to the psychostimulants cocaine and methamphetamine. The effects of dopamine and psychostimulants on the phosphorylation of GluR1 were attenuated in dopamine and cAMP-regulated phosphoprotein M(r) 32 kDa (DARPP-32) knock-out mice. These results identify DARPP-32 and AMPA-type glutamate receptors as likely essential cellular effectors for psychostimulant actions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844017      PMCID: PMC6772453     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain.

Authors:  R S Petralia; R J Wenthold
Journal:  J Comp Neurol       Date:  1992-04-15       Impact factor: 3.215

2.  DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Authors:  A A Fienberg; N Hiroi; P G Mermelstein; W Song; G L Snyder; A Nishi; A Cheramy; J P O'Callaghan; D B Miller; D G Cole; R Corbett; C N Haile; D C Cooper; S P Onn; A A Grace; C C Ouimet; F J White; S E Hyman; D J Surmeier; J Girault; E J Nestler; P Greengard
Journal:  Science       Date:  1998-08-07       Impact factor: 47.728

3.  Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression.

Authors:  K Kameyama; H K Lee; M F Bear; R L Huganir
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

Review 4.  Signal transduction pathways modulated by the D2 subfamily of dopamine receptors.

Authors:  R M Huff
Journal:  Cell Signal       Date:  1996-09       Impact factor: 4.315

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

Authors:  H C Hemmings; P Greengard; H Y Tung; P Cohen
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

Review 7.  Excitatory amino acids as a final common pathway for neurologic disorders.

Authors:  S A Lipton; P A Rosenberg
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

8.  Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases.

Authors:  L Y Wang; M W Salter; J F MacDonald
Journal:  Science       Date:  1991-09-06       Impact factor: 47.728

9.  Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons.

Authors:  S E Tan; R J Wenthold; T R Soderling
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

10.  NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus.

Authors:  H K Lee; K Kameyama; R L Huganir; M F Bear
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

View more
  106 in total

Review 1.  Regulation of AMPA receptors by phosphorylation.

Authors:  A L Carvalho; C B Duarte; A P Carvalho
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats.

Authors:  Soledad Cabeza de Vaca; Xing-Xiang Peng; Seth Concors; Casey Farin; Elena Lascu; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2011-12-07       Impact factor: 4.530

Review 3.  Regulation of AMPA receptor activity, synaptic targeting and recycling: role in synaptic plasticity.

Authors:  André R Gomes; Susana S Correia; Ana Luísa Carvalho; Carlos B Duarte
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

4.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

5.  DARPP-32: A molecular switch at the nexus of reward pathway plasticity.

Authors:  Todd D Gould; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-04       Impact factor: 11.205

Review 6.  Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity.

Authors:  John Q Wang; Anish Arora; Lu Yang; Nikhil K Parelkar; Guochi Zhang; Xianyu Liu; Eun Sang Choe; Limin Mao
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

7.  Psychostimulants, Protein phosphorylation and Gene expression: a growing role of L-type calcium channels.

Authors:  Anjali M Rajadhyaksha; Barry E Kosofsky
Journal:  Cellscience       Date:  2005-07-29

8.  Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex.

Authors:  Jill R Bordelon; Yoland Smith; Angus C Nairn; Roger J Colbran; Paul Greengard; E Chris Muly
Journal:  Cereb Cortex       Date:  2005-03-09       Impact factor: 5.357

Review 9.  Striatal glutamatergic mechanisms and extrapyramidal movement disorders.

Authors:  Thomas N Chase; Francesco Bibbiani; Justin D Oh
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex.

Authors:  Carlos Gonzalez-Islas; John J Hablitz
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.